Avanzanite

Avanzanite is a commercial-stage pharmaceutical company with the mission to redefine the commercialization of orphan drugs to improve patient access in Europe and beyond. Avanzanite's financial goal is to provide end-to-end commercialization and distribution partnerships for research-based biopharmaceutical originators, unlocking the full potential of their orphan drugs in the European market. The company’s humanitarian objective stems from their commitment to delivering innovative medicines to patients suffering from orphan diseases.